The Fresenius Principles form the basis of our company culture, with which we support #FutureFresenius and Fresenius Kabi’s Vision 2026 strategy. The Fresenius Principles describe what we stand for and how we operate, collaborate, approach challenges and make decisions – as individual Fresenius employees and as a whole team.
A Company Built on a Promise
Here for people today and tomorrow
What guides us
The Fresenius Principles
We serve patients beyond expectations
Bold in our ambitions. Turning ideas into actions.
We care for excellence
No compromise on quality. True north in mind.
We bring healthcare innovation to people
Learning with our customers and partners. Pushing therapies to the next level.
We live the power of One Team
Respectful collaboration. Empowering responsibility.
We act today for a better tomorrow
Over 100 years of heritage. Mindful of future needs and resources.
The face(s) of care
The Fresenius Group structure
Stronger together
We are proud to be part of the Fresenius Group with its more than 175,000 employees worldwide. Every day, we use all dedication, expertise, and passion to help advance healthcare opportunities and make a difference in people’s lives everywhere. Together, the Fresenius Group has a combined annual revenue of €21.5 billion with a positive financial forecast for the coming years.
Operating companies
Fresenius Kabi
Assisting critically and chronically ill patients with quality solutions for infusion, transfusion, and clinical nutrition.
2024 sales > €8.4 billion
Fresenius Helios
Making an impact as Europe’s leading private hospital operator with HELIOS and Quirónsalud hospitals.
2024 sales > €12.7 billion
Learn more about Fresenius Helios
Investment companies
Fresenius Medical Care
Helping people with chronic kidney failure live their best lives through comprehensive products and services.
Learn more about Fresenius Medical Care
Fresenius Vamed
Equipping global hospitals and healthcare facilities with the solutions they need for optimal outcomes.
Learn more about Fresenius Vamed
Consistent, long-term growth
A strong foundation to build on
As a company, we have continued to experience organic growth in all our key market sectors. Our broad industrial base, comprehensive range of system-critical healthcare products and leading market positions in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. A clear financial strategy, combined with a high-performing team and a new leadership with revised governance ensures a profitable and productive future.